Published September 30, 2020 | Version v1

Journal article Metadata-only

Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab

Creators: Bouhlel, Linda; Doyen, Jérôme; Chamorey, Emmanuel; Poudenx, Michel; Ilie, Marius; Gal, Jocelyn; Guigay, Joël; Benzaquen, Jonathan; Marquette, Charles-Hugo; Berthet, Jean-Philippe; Mouroux, Jérôme; Schiappa, Renaud; Padovani, Bernard; Hofman, Paul; Otto, Josiane

Other:: Université Côte d'Azur (UCA)

Additional details

Created:: December 3, 2022
Modified:: November 30, 2023